Latest From Vyteris Inc.
Drug Delivery Partnership Strategies – Case studies in effective licensing, collaboration and therapeutic differentiation
Innovative drug delivery technologies are playing an increasingly important role in extending lifecycles, differentiating me-too products and unlocking the value of new compounds with challenging delivery requirements, writes Steven Seget in a report from Scrip Insights.
Our monthly update on technology transfer deals--licensing agreements between companies and universities or other research institutions--in the fields of life sciences, including pharmaceuticals, medical devices, in vitro diagnostics and research/analytical instrumentation and reagents.
The drug delivery device industry is on track to reach almost $23 billion by the year 2011, and the fastest growth will come from the transdermal sector. According to a recent Windhover Information/Medtech Insight report, transdermal delivery technologies will build up to sales of $4.6 billion by 2011. Pharma's increasing fondness for macromolecules will fuel that growth, as will the perennially hot market for transdermal formulations of pain drugs.
Transdermal drug delivery has come a long way since the first patch for seasickness. In a drug delivery device industry on track to reach almost $23 billion by the year 2011 (according to "US Markets for Drug and Fluid Delivery Devices," published in October 2007 by Windhover Information's Medtech Insight division) the transdermal sector will grow at a faster rate than injection or inhalation drug delivery systems. Transdermal delivery technologies will grow at a compound annual rate of more than 11% over the next four years, building up to sales of $3.5 billion in the year 2011.
- Large Molecule
- Medical Devices
- Drug Delivery
- Therapeutic Areas
- Gynecological, Urological
- Neurology, Nervous System
- Vyteris Holdings Inc.
- North America
- Parent & Subsidiaries
- Vyteris Inc.
- Senior Management
Haro Hartounian, PhD, Pres. & CEO
Joseph Himy, CFO
Michael Reidy, PhD, VP, R&D
Eric Pluckhorn, SVP, Sales & Mktg.
- Contact Info
Phone: (201) 703-2299
13-01 Pollitt Dr.
Fair Lawn, NJ 07410
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.